Javitt Daniel C, Freedman Robert
From the Division of Experimental Therapeutics, Department of Psychiatry, Columbia University Medical Center, and the Program in Cognitive Neuroscience and Schizophrenia, Nathan Kline Institute for Psychiatric Research, New York; and the Department of Psychiatry, University of Colorado Denver School of Medicine, Aurora.
Am J Psychiatry. 2015 Jan;172(1):17-31. doi: 10.1176/appi.ajp.2014.13121691. Epub 2014 Nov 17.
Sensory processing deficits, first investigated by Kraepelin and Bleuler as possible pathophysiological mechanisms in schizophrenia, are now being recharacterized in the context of our current understanding of the molecular and neurobiological brain mechanisms involved. The National Institute of Mental Health Research Domain Criteria position these deficits as intermediaries between molecular and cellular mechanisms and clinical symptoms of schizophrenia, such as hallucinations. The prepulse inhibition of startle responses by a weaker preceding tone, the inhibitory gating of response to paired sensory stimuli characterized using the auditory P50 evoked response, and the detection of slight deviations in patterns of sensory stimulation eliciting the cortical mismatch negativity potential demonstrate deficits in early sensory processing mechanisms, whose molecular and neurobiological bases are increasingly well understood. Deficits in sensory processing underlie more complex cognitive dysfunction and are in turn affected by higher-level cognitive difficulties. These deficits are now being used to identify genes involved in familial transmission of schizophrenia and to monitor potentially therapeutic drug effects for both treatment and prevention. This research also provides a clinical reminder that patients' sensory perception of the surrounding world, even during treatment sessions, may differ considerably from others' perceptions. A person's ability to understand and interact effectively with the surrounding world ultimately depends on an underlying sensory experience of it.
感觉加工缺陷最初由克雷佩林和布鲁勒作为精神分裂症可能的病理生理机制进行研究,如今在我们对所涉及的分子和神经生物学脑机制的当前理解背景下正被重新界定。美国国立精神卫生研究所的研究领域标准将这些缺陷定位为分子与细胞机制和精神分裂症临床症状(如幻觉)之间的中介。较弱的前导音对惊吓反应的前脉冲抑制、使用听觉P50诱发反应表征的对配对感觉刺激反应的抑制性门控,以及对引发皮质失配负波电位的感觉刺激模式中轻微偏差的检测,都证明了早期感觉加工机制存在缺陷,其分子和神经生物学基础正日益为人所理解。感觉加工缺陷是更复杂认知功能障碍的基础,反过来又受到更高层次认知困难的影响。这些缺陷如今正被用于识别精神分裂症家族传递中涉及的基因,并监测潜在治疗药物对治疗和预防的效果。这项研究还提供了一个临床提示,即患者对周围世界的感觉认知,即使在治疗期间,也可能与其他人的认知有很大差异。一个人理解并有效与周围世界互动的能力最终取决于对其潜在的感觉体验。